Accendra Health Stock Forecast
NYSE: ACHHealthcareMedical DistributionUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
ACH analyst consensus
Consensus (5 analysts)
hold
Avg. price target
$1.51+240.70%
- Strong buy 0
- Buy 0
- Hold 3
- Sell 0
- Strong sell 2
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 5 Wall Street analysts covering Accendra Health (2026-10-09), 0 rate the stock a buy or strong buy, 3 rate it a hold and 2 rate it a sell or strong sell, for a consensus rating of "hold". The average 12-month price target is $1.51, with a high estimate of $1.75 and a low estimate of $1.30. The average target implies upside of 240.7% from the current price of $0.4432.
The spread between the highest and lowest targets is 34.6%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for ACH.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 0 | 0% |
| Buy | 0 | 0% |
| Hold | 3 | 60% |
| Sell | 0 | 0% |
| Strong sell | 2 | 40% |
Ratings as of 2026-10-09.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $1.30 | +193.32% |
| Average target | $1.51 | +240.70% |
| High target | $1.75 | +294.86% |
How analysts view Accendra Health's peers
| Company | Consensus | Price | Avg. target | Implied move |
|---|---|---|---|---|
| COSM | strong_buy | 0.3144 | $4.50 | +1331.30% |